CLARIANE Stock Rebounds 3.43% at the Close of November 10
After several weeks of turbulence, the stock of the European long-term care manager regains some momentum this Monday. At the close, CLARIANE was up at €3.44, a…
Follow today's market news in real time: CAC 40 prices, corporate announcements, financial releases and market information. This page automatically aggregates the latest briefs and press releases to give you the most up-to-date view of the moves driving the session.
After several weeks of turbulence, the stock of the European long-term care manager regains some momentum this Monday. At the close, CLARIANE was up at €3.44, a…
The luxury giant's stock closed higher on Monday, gaining 3.52% to €310.45. This increase comes in a context of revitalization of the stock price over several m…
Capgemini's stock saw a significant rise at the close, gaining 4.13% to 128.45 euros. The rebound is welcomed after a volatile week, while the CAC 40 index itse…
MEDINCELL closed Monday at 29.48 euros, down 6.71% from the previous close. This correction follows a rally of 84.48% over the past three months. The movement c…
The Paris Stock Exchange saw a significant rise by midday on Monday, with the CAC 40 climbing 1.27% in a movement that reflects a resurgence of confidence follo…
The French payment technology specialist's stock rebounds at midday, reaching €1.95 after a week marked by a severe correction. This movement comes after a day …
Imerys stock accelerates at midday on Monday, recovering from recent losses. The share of the global leader in mineral specialties has risen by 5.24%, significa…
On Monday, November 10, THEON INTERNAT's stock marked a significant morning increase, rising to €28.60 from €27.15 at last Friday's close, a rebound of 5.34%. T…
NANOBIOTIX shows solid progress this Monday, gaining 8.81% and surpassing the 18.50 euro mark mid-session. After experiencing a significant decline earlier in t…
Midday this Monday, November 10, EMEIS stock is accelerating, driven by a major announcement for the group. Emeis SA has reached a principle agreement on new fi…
This morning, the French biotech stock is regaining ground at the Paris Stock Exchange, showing a clear recovery after a strongly bearish session at the start o…
EMEIS shares are experiencing a significant upward trend, driven by a principle refinancing agreement announced on November 10, 2025, which has reinvigorated th…
Euronext has received approval from the Hellenic Capital Market Commission for the revision of its share exchange offer on Hellenic Exchanges - Athens Stock Exc…
Genfit announces a research collaboration with EVerZom to develop exosome-based technologies in the field of regeneration, particularly for ACLF.
Emeis has reached a principle agreement with its banking partners and financial investors to refinance its debt, allowing for an early exit from its accelerated…
DISCLAIMER: This information is not contractual in nature and carries no guarantee of accuracy. It should not be considered investment advice. Ideal-investisseur.fr cannot be held liable for any damages or losses arising from the use of this information.
